87 related articles for article (PubMed ID: 18785801)
1. IMP3: a diagnostic and prognostic biomarker in malignant melanoma.
Xu H
Expert Rev Mol Diagn; 2008 Sep; 8(5):557-8. PubMed ID: 18785801
[No Abstract] [Full Text] [Related]
2. [Genetic markers of melanoma].
Tronov VA; Artamonov DN; Gorbacheva LB
Genetika; 2010 Feb; 46(2):168-79. PubMed ID: 20297650
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant melanoma of the rectum arising against a background of rectal melanosis.
Righi A; Dimosthenous K
Int J Surg Pathol; 2008 Jul; 16(3):335-6. PubMed ID: 18573790
[No Abstract] [Full Text] [Related]
4. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
[TBL] [Abstract][Full Text] [Related]
5. Stratum corneum RNA levels are diagnostic for melanoma.
Grichnik JM
Br J Dermatol; 2011 Apr; 164(4):693-4. PubMed ID: 21457197
[No Abstract] [Full Text] [Related]
6. A new piece in the melanoma mosaic--carcinosarcoma-like melanoma.
Svec A; Wilkinson L; Bury Y; Martin VG
Histopathology; 2009 Sep; 55(3):366-8. PubMed ID: 19723157
[No Abstract] [Full Text] [Related]
7. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of c-myc oncoprotein levels in malignant melanoma.
Ekwobi CC
J Plast Reconstr Aesthet Surg; 2008; 61(4):464. PubMed ID: 18249164
[No Abstract] [Full Text] [Related]
9. Tenascin C: a defensive role in sentinel lymph nodes of melanoma patients?
Gazzaniga P; Cigna E; Vincenzi B; Bottoni U; Vasaturo F; Alfano C; Calvieri S; Frati L; Scuderi N; Aglianò AM; Gradilone A
J Dermatol Sci; 2009 Mar; 53(3):239-41. PubMed ID: 19070467
[No Abstract] [Full Text] [Related]
10. Effusion cytomorphology and immunocytochemistry of malignant melanoma: five cases of melanotic melanoma and one case of amelanotic melanoma.
Ikeda K; Tate G; Iezumi K; Suzuki T; Kitamura T; Mitsuya T
Diagn Cytopathol; 2009 Jul; 37(7):516-21. PubMed ID: 19301358
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin protein expression in cutaneous melanocytic lesions.
Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
[TBL] [Abstract][Full Text] [Related]
12. A firm red-brown plaque on the arm. Dermatofibrosarcoma protuberans(DFSP), pigmented variant (Bednar tumor.
Quigley EA; Marghoob AA; Busam KJ; Chen CS
Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451510
[No Abstract] [Full Text] [Related]
13. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
Dauplat MM; Penault-Llorca F
Ann Pathol; 2009 Jun; 29(3):228-32. PubMed ID: 19619831
[No Abstract] [Full Text] [Related]
14. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
[TBL] [Abstract][Full Text] [Related]
15. [Clinicobiochemical study of diagnostic value of the panel including 10 potential protein markers of prostatic cancer].
Shishkin SS; Dzeranov NK; Totrov KI; Kazachenko AV; Kovaleva MA; Toropygin IIu
Urologiia; 2009; (1):56-8. PubMed ID: 19432234
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.
Hofmann MA; Gussmann F; Fritsche A; Biesold S; Schicke B; Küchler I; Voit C; Trefzer U
Melanoma Res; 2009 Feb; 19(1):17-23. PubMed ID: 19104451
[TBL] [Abstract][Full Text] [Related]
18. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
19. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
20. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
Bolander A; Agnarsdóttir M; Wagenius G; Strömberg S; Pontén F; Ekman S; Brattström D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M
Melanoma Res; 2008 Dec; 18(6):412-9. PubMed ID: 19011512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
